SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Intellia Therapeutics is currently a focal point of intense investor interest as the community awaits crucial Phase 3 data for its gene editing candidate and monitors the regulatory progress of its cardiac pipeline. With short interest levels remaining elevated, investors are actively debating the potential for a volatile move driven by upcoming clinical readouts and the possibility of a squeeze.

Atomera, Inc. engages in the development, commercialization, and licensing of proprietary processes and technologies for the semiconductor industry. It developed Mears Silicon Technology, which increases performance and power efficiency in semiconductor transistors. The company was founded by Robert Mears on November 26, 2001 and is headquartered in Los Gatos, CA.

Atomera Inc

Atomera is seeing a surge in investor attention as the community anticipates news regarding potential Joint Development Agreements and commercial licensing deals tied to its Mears Silicon Technology, particularly within the Gate-All-Around and DRAM sectors. Traders are closely monitoring the stock's significant volume and price volatility, driven by speculation over partnerships with major semiconductor foundries and equipment manufacturers amid a broader focus on AI infrastructure.

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

CRISPR Therapeutics AG

CRISPR Therapeutics is facing downward pressure following a series of insider share sales, which has sparked frustration among retail investors already concerned by the company's long-term capital efficiency and commercial ramp-up. Despite the negativity, the community remains divided between those calling for a strategic buyout or management change and long-term believers who are leveraging the dip to accumulate shares based on the company's extensive gene-editing pipeline and substantial cash position.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is seeing a massive surge in market interest, driven by speculation over potential partnerships with major hyperscalers and its critical role in AI optical interconnects. The community is actively discussing the stock's parabolic volume and momentum, with longs celebrating the potential for a sustained breakout while shorts remain under intense pressure.

APE fuels culture. Backed by the best club in the world and hundreds of thousands of holders worldwide, it’s the token for digital and IRL communities, builders, creators, collectors, gamers, and beyond.  APE is the native gas token of ApeChain and is available across multiple ecosystems including Ethereum, Arbitrum, Solana and HyperLiquid.z  ApeCoin's mission is is to supercharge its ecosystem by supporting high-quality builders &amp; reinforcing 3 core pillars: ApeChain, Bored Ape Yacht Club, and Otherside.

ApeCoin

ApeCoin is seeing a surge in investor attention and high-volume volatility, fueled by the launch of ApeChain and the influx of new on-chain projects. The community remains divided, with some traders highlighting the token's aggressive, flow-driven momentum while others express frustration over long-term price performance and historical dilution concerns.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo is experiencing heightened volatility and strong community interest following a strategic collaboration with NVIDIA and Los Alamos National Laboratory, which is fueling excitement around the company's role in powering AI infrastructure. While bullish investors point to these institutional partnerships and potential regulatory catalysts as long-term drivers, others remain cautious, citing the company's pre-revenue status and recent insider selling activity.

MaxLinear, Inc. engages in the provision of communications systems-on-chip (SoC) solutions used in broadband, mobile and wireline infrastructure, data center, and industrial and multi-market applications. Its products include cable broadband modems and gateways, wireline connectivity devices, radio frequency transceivers, fiber-optic modules, video set-top boxes and gateways, hybrid analog and digital televisions, direct broadcast satellite outdoor and indoor units, and power management and interface products. The company was founded by Kimihiko Imura, Curtis C. Ling, and Kishore V. Seendripu on September 25, 2003 and is headquartered in Carlsbad, CA.

MaxLinear Inc

MaxLinear is currently trending as traders aggressively reprice the stock following a significant earnings beat and raised guidance that highlights its growing role in AI-driven data center infrastructure. The community remains divided, with bulls pointing to fundamental momentum and institutional interest, while bears warn of a potential overvaluation and pump-and-dump mechanics after the recent parabolic price move.

iShares Trust - iShares Semiconductor ETF

iShares Semiconductor ETF

iShares Semiconductor ETF is experiencing intense volatility and record-breaking volume as traders debate whether the sector's parabolic run represents an unsustainable bubble or a continued momentum-driven surge. Community sentiment is deeply divided, with many actively hedging against a potential blow-off top while others remain focused on the sector's long-term dominance in AI infrastructure.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network is gaining momentum as investors eye upcoming industry events and potential integration news, with the community actively debating the project's utility versus broader market volatility. Enthusiasts are focusing on long-term growth and technical accumulation, while discussion remains divided between those expecting significant adoption and others expressing caution over price trends.

X-Energy, Inc. operates as an energy company The firm focuses on modular nuclear reactors and fuel technology for clean energy generation. The company was founded by Kam Ghaffarian and Eben Mulder on 2009 and is headquartered in Rockville, MD.

X-Energy Inc. - Ordinary Shares- Class A

X-energy Inc

X-energy is capturing significant market attention following its public debut, with investors closely watching the nuclear developer's strategic partnerships with major tech giants like Amazon to fuel AI infrastructure demand. While the community is debating the stock's valuation and long-term viability, the conversation is largely driven by high initial demand and the broader narrative surrounding the role of small modular reactors in solving energy bottlenecks.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

W. R. Berkley Corporation Names R. Christopher DeLauder President of Berkley Environmental

W. R. Berkley Corporation (NYSE: WRB) today announced the appointment of R. Christopher DeLauder as president of Berkley Environmental. He succeeds Kenneth J. Berger, who has been named chair of the...

Globe Life Q1 Earnings Miss Estimates, Rise Y/Y on Higher Premiums

Globe Life's Q1 earnings miss estimates despite higher premiums and underwriting gains, as rising expenses weigh on results.

RLI Q1 Earnings Miss Estimates, Investment Income Increases Y/Y

RLI misses Q1 estimates as catastrophe losses weigh on underwriting, though investment income and casualty growth help offset pressure.

Selective Insurance Q1 Earnings Miss Estimates, Revenues Increase Y/Y

SIGI's Q1 earnings miss estimates as catastrophe losses and weak underwriting hit profits, despite strong investment income and modest revenue growth.

W.R. Berkley's Q1 Earnings Surpass Estimates, Revenues Miss

WRB posts mixed Q1 results with revenue growth and higher investment income, but misses estimates as premiums come in slightly below expectations.

Wells Fargo & Company Has Lowered Expectations for W.R. Berkley (NYSE:WRB) Stock Price

Wells Fargo & Company cut their target price on shares of W.R. Berkley from $66.00 to $64.00 and set an "equal weight" rating for the company in a research note on Wednesday...

CB Q1 Earnings & Revenues Beat on Higher Underwriting Profit

Chubb Limited's Q1 results reflect strong growth in P&C underwriting income, investment income, life income and improved combined ratio.

W.R. Berkley (NYSE:WRB) Price Target Raised to $64.00

Barclays raised their target price on shares of W.R. Berkley from $62.00 to $64.00 and gave the stock an "underweight" rating in a research note on Wednesday...

These Analysts Revise Their Forecasts On WR Berkley After Q1 Earnings

WR Berkley (NYSE: WRB) reported mixed Q1 results, beating earnings but missing sales estimates. Analysts have adjusted their price targets.read more...

Here's Why W.R. Berkley (WRB) is a Strong Value Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

W.R. Berkley Corp. is an insurance holding company, which engages in the property casualty insurance business. It operates through the following segments: Insurance and Reinsurance & Monoline Excess. The Insurance segment includes excess and surplus lines, admitted lines, and specialty personal lines throughout the United States, as well as insurance businesses in the United Kingdom, Continental Europe, South America, Canada, Mexico, Scandinavia, Asia, and Australia. The Reinsurance & Monoline Excess segment is involved in the reinsurance business on a facultative and treaty basis, primarily in the United States, United Kingdom, Continental Europe, Australia, the Asia-Pacific region, and South Africa. The company was founded by William R. Berkley in 1967 and is headquartered in Greenwich, CT.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	$1.10	--	--	N/A
Q1 '26	$1.13	$1.30	14.58%	BEAT
Q4 '25	$1.13	$1.13	0.21%	BEAT
Q3 '25	$1.11	$1.10	-0.57%	MISSED
Q2 '25	$1.03	$1.05	2.27%	BEAT

WRB
W.R. Berkley Corp.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q1 '26

Historical Earnings

Latest WRB News

WRBW.R. Berkley Corp.